H, O., JW, T., T, N., D, G., PB, W., K, O., . . . H, O. (2022). Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas. The Journal of clinical investigation, 132(3), . https://doi.org/10.1172/JCI151239
Chicago Style (17th ed.) CitationH, Ogino, et al. "Randomized Trial of Neoadjuvant Vaccination with Tumor-cell Lysate Induces T Cell Response in Low-grade Gliomas." The Journal of Clinical Investigation 132, no. 3 (2022). https://doi.org/10.1172/JCI151239.
MLA (9th ed.) CitationH, Ogino, et al. "Randomized Trial of Neoadjuvant Vaccination with Tumor-cell Lysate Induces T Cell Response in Low-grade Gliomas." The Journal of Clinical Investigation, vol. 132, no. 3, 2022, https://doi.org/10.1172/JCI151239.